Search Results - David E. Griffith
- Showing 1 - 20 results of 38
- Go to Next Page
-
1
Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis by Barbara Seaworth, David E. Griffith
Published 2017Revisão -
2
Understanding nontuberculous mycobacterial lung disease: it’s been a long time coming by David E. Griffith, Timothy R. Aksamit
Published 2016Pré-impressão -
3
-
4
-
5
Non-tuberculous mycobacterial pulmonary disease by Steven Cowman, Jakko van Ingen, David E. Griffith, Michael R. Loebinger
Published 2019Revisão -
6
-
7
-
8
-
9
-
10
-
11
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections by Richard J. Wallace, Gary Dukart, Barbara A. Brown‐Elliott, David E. Griffith, Ernesto G. Scerpella, Ben G. Marshall
Published 2014Artigo -
12
-
13
Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease by Julie V. Philley, Richard J. Wallace, Jeana L. Benwill, Varsha Taskar, Barbara A. Brown‐Elliott, Foram Thakkar, Timothy R. Aksamit, David E. Griffith
Published 2015Artigo -
14
Semiquantitative Culture Analysis during Therapy for <i>Mycobacterium avium</i> Complex Lung Disease by David E. Griffith, Jennifer Adjemian, Barbara A. Brown‐Elliott, Julie V. Philley, D. Rebecca Prevots, Christopher Gaston, Kenneth N. Olivier, Richard J. Wallace
Published 2015Artigo -
15
Role of NK Cell-Activating Receptors and Their Ligands in the Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium by Ramakrishna Vankayalapati, Ankita Garg, Angel Porgador, David E. Griffith, Peter Klucar, Hassan Safi, William M. Girard, David Cosman, Thomas A. Spies, Peter F. Barnes
Published 2005Artigo -
16
Binding of CXCL8/IL-8 to<i>Mycobacterium tuberculosis</i>Modulates the Innate Immune Response by Agnieszka Krupa, Marek Fol, Bożena Dziadek, Ewa Kępka, Dominika Wojciechowska, Anna Brzostek, Agnieszka Torzewska, Jarosław Dziadek, Robert P. Baughman, David E. Griffith, Anna Kurdowska
Published 2015Artigo -
17
<i>In Vitro</i> Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated Isolates by Barbara A. Brown‐Elliott, Elena Iakhiaeva, David E. Griffith, Gail L. Woods, Jason E. Stout, Cameron R. Wolfe, Christine Y. Turenne, Richard J. Wallace
Published 2013Artigo -
18
Repeat Positive Cultures in<i>Mycobacterium intracellulare</i>Lung Disease after Macrolide Therapy Represent New Infections in Patients with Nodular Bronchiectasis by Richard J. Wallace, Yansheng Zhang, Barbara A. Brown‐Elliott, Mitchell A. Yakrus, Rebecca W. Wilson, Linda Mann, Leslie Couch, William M. Girard, David E. Griffith
Published 2002Artigo -
19
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases by Jakko van Ingen, Dirk Wagner, Jack R. Gallagher, Kozo Morimoto, Christoph Lange, Charles Haworth, R. Andres Floto, Jennifer Adjemian, D. Rebecca Prevots, David E. Griffith
Published 2016Carta -
20
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease by Richard J. Wallace, Barbara A. Brown‐Elliott, Steven G. McNulty, Julie V. Philley, Jessica Killingley, Rebecca W. Wilson, Deanna York, Sara Shepherd, David E. Griffith
Published 2014Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Pathology
Tuberculosis
Mycobacterium
Biology
Lung
Intensive care medicine
Microbiology
Nontuberculous mycobacteria
Disease
Sputum
Bronchiectasis
Antibiotics
Immunology
Surgery
Mycobacterium abscessus
Culture conversion
Regimen
Sputum culture
Bacteria
Gastroenterology
Genetics
Lung disease
Adverse effect
Cystic fibrosis
Mycobacterium tuberculosis
Azithromycin
Bedaquiline
Clarithromycin